FDA Advisory Committee Meeting
Joint
Meeting of the Endocrinilogic and Metabolic Drugs Advisory Committee
and the Drug Safety and Risk Management Advisory Committee
June 5-6, 2013 – FDA White Oak Campus
On both days, the committees will discuss the
results of an independent readjudication of the Rosiglitazone Evaluated
for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes
(RECORD) trial. Rosiglitazone (AVANDIA) is used as an adjunct to diet
and exercise to improve glycemic control in adults with type 2 diabetes
mellitus.
View the full meeting announcement and materials. Generic Drug User Fee Amendments of 2012/ Regulatory Science Initiatives
June 21, 2013 – FDA White Oak Campus
FDA will be holding a public meeting to
provide an overview of the current regulatory science initiatives for
generic drugs and to solicit public input on research priorities in this
area. FDA will take the information it obtains from the public meeting
into account in developing the 2014 Regulatory Science Plan.
View the meeting announcement. Check out an OWH exhibit booth or presentation at
one of these conferences to learn more about OWH programs, research, and
free educational resources.
American Academy of Physician Assistants, May 28-29 – Washington, DC
American College Health Association, May 28-Jun 1 – Boston, MA
YWCA, Jun 5-8 – Washington, DC
American Academy of Nurse Practitioners, Jun 20-22 – Las Vegas, NV
American Library Association, Jun 28-Jul 1 – Chicago, IL
American Association of Colleges of Pharmacy, Jul 13-17 – Chicago, IL
National Council of La Raza, Jul 20-23 – New Orleans, LA
National Black Nurses Association, Aug 1-3 – New Orleans, LA
|
